HSTC:DHD (Vietnam)
Â
â‚«
36,000
+1,000 (+2.86%)
Apr 10
What is a stock summary page? Click here for an overview.
Business Description
Hai Duong Pharmaceutical Medical Material JSC
ISIN : VN000000DHD7
Description
Hai Duong Pharmaceutical Medical Material JSC is a reliable pharmaceutical company in Vietnam. Its manufacture, import, and export pharmaceutical products, chemicals, medical materials, foods, and cosmetics. It is also engaged in the construction, estate service, and healthcar business.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Piotroski F-Score | N/A/9 | |||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 66.78 | |||||
| 9-Day RSI | 58.78 | |||||
| 14-Day RSI | 56.44 | |||||
| 3-1 Month Momentum % | 27.66 | |||||
| 6-1 Month Momentum % | 35.34 | |||||
| 12-1 Month Momentum % | 70.07 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.83 | |||||
| Forward Dividend Yield % | 0.83 | |||||
| 5-Year Yield-on-Cost % | 0.86 |
Profitability Rank
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | N/A |
N/A
|
N/A
| |||
| PE Ratio without NRI | N/A |
N/A
|
N/A
|
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hai Duong Pharmaceutical Medical Material JSC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚«) | |||
| EPS (TTM) (â‚«) | - | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | 1.48 | ||
| 3-Year Sortino Ratio | 3.51 | ||
| Volatility % | 17.4 | ||
| 14-Day RSI | 56.44 | ||
| 14-Day ATR (â‚«) | 786.778605 | ||
| 20-Day SMA (â‚«) | 35305 | ||
| 12-1 Month Momentum % | 70.07 | ||
| 52-Week Range (â‚«) | 21167.883211 - 39000 | ||
| Shares Outstanding (Mil) |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hai Duong Pharmaceutical Medical Material JSC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hai Duong Pharmaceutical Medical Material JSC Stock Events
| Event | Date | Price (â‚«) | ||
|---|---|---|---|---|
| No Event Data | ||||
Hai Duong Pharmaceutical Medical Material JSC Frequently Asked Questions
What is Hai Duong Pharmaceutical Medical Material JSC(HSTC:DHD)'s stock price today?
The current price of HSTC:DHD is â‚«36000.00. The 52 week high of HSTC:DHD is â‚«39000.00 and 52 week low is â‚«21167.88.
When is next earnings date of Hai Duong Pharmaceutical Medical Material JSC(HSTC:DHD)?
The next earnings date of Hai Duong Pharmaceutical Medical Material JSC(HSTC:DHD) is .
Does Hai Duong Pharmaceutical Medical Material JSC(HSTC:DHD) pay dividends? If so, how much?
The Dividend Yield %  of Hai Duong Pharmaceutical Medical Material JSC(HSTC:DHD) is 0.83% (As of Today), Highest Dividend Payout Ratio of Hai Duong Pharmaceutical Medical Material JSC(HSTC:DHD) was 0. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of Hai Duong Pharmaceutical Medical Material JSC(HSTC:DHD) is 0.83%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers